AARTIPHARM — Aarti Pharmalabs Share Price
0.000.00%
Last trade - 00:00- IN₹66.63bn
- IN₹69.45bn
- IN₹18.53bn
- 54
- 20
- 83
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.59 | ||
| Price to Tang. Book | 3.78 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.24 | ||
| EV to EBITDA | 15.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.87% | ||
| Return on Equity | 14.19% | ||
| Operating Margin | 17.16% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 11,999.43 | 19,452.33 | 18,526.09 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -20.82 | +11.9 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 22nd, 2019
- Public Since
- January 30th, 2023
- No. of Shareholders
- 208,825
- No. of Employees
- 1,627
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 90,634,624
- Address
- 2nd Floor, 204, MUMBAI, 400080
- Web
- https://www.aartipharmalabs.com/
- Phone
- +91 2269436100
- Auditors
- Gokhale & Sathe
Upcoming Events for AARTIPHARM
Q1 2026 Aarti Pharmalabs Ltd Earnings Release
Aarti Pharmalabs Ltd Annual Shareholders Meeting
Similar to AARTIPHARM
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
Ajanta Pharma
National Stock Exchange of India
FAQ
What is the Aarti Pharmalabs share price?
As of Today at 19:00 UTC, shares in Aarti Pharmalabs are trading at IN₹735.15. This share price information is delayed by 15 minutes.
How has the Aarti Pharmalabs share price performed this year?
Shares in Aarti Pharmalabs last closed at IN₹735.15 and the price had moved by +38.23% over the past 365 days. In terms of relative price strength the Aarti Pharmalabs share price has outperformed the S&P BSE 100 Index by +30.21% over the past year.
What are the analyst and broker recommendations for Aarti Pharmalabs?
There is no consensus recommendation for this security.
Find out moreWhat is the Aarti Pharmalabs dividend yield?
The Aarti Pharmalabs dividend yield is 0.48% based on the trailing twelve month period.
Does Aarti Pharmalabs pay a dividend?
Last year, Aarti Pharmalabs paid a total dividend of IN₹3.50, and it currently has a trailing dividend yield of 0.48%. We do not have any data on when Aarti Pharmalabs is to next pay dividends.
When does Aarti Pharmalabs next pay dividends?
We do not have data on when Aarti Pharmalabs is to next pay dividends. The historic dividend yield on Aarti Pharmalabs shares is currently 0.48%.
How do I buy Aarti Pharmalabs shares?
To buy shares in Aarti Pharmalabs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aarti Pharmalabs?
As of the previous close price of IN₹735.15, shares in Aarti Pharmalabs had a market capitalisation of IN₹66.63bn.
Where are Aarti Pharmalabs shares listed?
Here are the trading details for Aarti Pharmalabs:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: AARTIPHARM
What kind of share is Aarti Pharmalabs?
Based on an overall assessment of its quality, value and momentum Aarti Pharmalabs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aarti Pharmalabs share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Aarti Pharmalabs share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aarti Pharmalabs. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +24%.
As of the last closing price of IN₹735.15, shares in Aarti Pharmalabs were trading +11.73% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aarti Pharmalabs PE Ratio?
The Aarti Pharmalabs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹735.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aarti Pharmalabs?
We do not have data on Aarti Pharmalabs' directors